BiVictriX Therapeutics

(BVX)
Sector: Pharmaceuticals & Biotechnology
10.00p
1.50p 17.65
Last updated: 16:57:07

Director dealings

Trade date Director Volume / Price Trade value Trade type
30/08/2024 Robert Edward Hawkins 20,000 @ 7.26p £1,452.00 Sell
30/08/2024 Robert Edward Hawkins 20,000 @ 7.26p £1,452.00 Buy
30/08/2024 Robert Edward Hawkins 20,000 @ 72.60p £14,520.00 Buy
13/09/2022 Michael Kauffman 75,000 @ $0.25 $18,750.00 Buy
12/09/2022 Iain Gladstone Ross 25,000 @ 17.90p £4,475.00 Buy
12/09/2022 Iain Gladstone Ross 30,000 @ 17.80p £5,340.00 Buy
12/09/2022 Iain Gladstone Ross 50,000 @ 17.70p £8,850.00 Buy
08/03/2022 Iain Gladstone Ross 100,000 @ 22.25p £22,250.00 Buy
21/12/2021 Tiffany Jane Thorn 10,000 @ 27.00p £2,700.00 Buy
20/12/2021 Tiffany Jane Thorn 25,000 @ 26.00p £6,500.00 Buy
02/11/2021 Robert Edward Hawkins 35,000 @ 21.90p £7,665.00 Buy
04/11/2021 Robert Edward Hawkins 20,000 @ 22.44p £4,488.00 Buy
03/11/2021 Robert Edward Hawkins 30,000 @ 24.62p £7,386.00 Buy
03/11/2021 Robert Edward Hawkins 15,000 @ 23.00p £3,450.00 Buy
22/09/2021 Iain Gladstone Ross 25,645 @ 19.45p £4,987.95 Buy
22/09/2021 Iain Gladstone Ross 30,848 @ 19.45p £5,999.94 Buy
22/09/2021 Iain Gladstone Ross 43,507 @ 19.37p £8,427.31 Buy

Director shareholdings

Name Holding Percent
Tiffany Jane Thorn 1,632,500 2.00%
Robert Edward Hawkins 325,000 0.00%
Michael Kauffman 75,000 0.00%
William Drummond Paris 75,000 0.00%

Major shareholders

Institution name Holding Percent
Development Bank of Wales 11,870,021 14.38%
Robert Keith 9,562,434 11.60%
Canaccord Genuity 9,076,924 11.00%
Spreadex Ltd 7,113,115 8.62%
Alderley Park Ventures 4,527,741 6.80%
Patronus Partners 2,694,512 4.10%
Walker Crips 2,545,000 3.80%
Alden AS 2,000,000 3.00%